The field of lymphatic research is at a turning point.

The United States government has committed more than $300 million through the Advanced Research Projects Agency for Health (ARPA-H) to support two landmark lymphatic programs: LIGHT, which stands for Lymphatic Imaging, Genomics, and pHenotyping Technologies, is focused on improving diagnosis, monitoring, imaging, and understanding of lymphatic dysfunction. GLIDE, which stands for Groundbreaking Lymphatic Interventions and Drug Exploration, is focused on advancing new therapeutic approaches that target abnormal lymphatic structure and function.

This is the first large-scale federal investment dedicated to lymphatic science.

To highlight this moment, Dr. Stanley G. Rockson, Stanford University, and the Lymphatic Education & Research Network (LE&RN), will host a Virtual Summit featuring the teams leading these efforts.

This event will be important for the entire LE&RN community. For patients and caregivers, it offers a meaningful opportunity to help shape how new technologies and therapies are developed from the start. For clinicians and therapists, it provides early insight into emerging tools and how they may be integrated into care. For researchers, it offers visibility into priorities, collaboration opportunities, and the future direction of the field. Join us to hear what this historic investment means for lymphatic science, lymphatic care, and the people we serve.